2017: A Big Year for AbSci – Growth and Continued Expansion

2017: A Big Year for AbSci – Growth and Continued Expansion

AbSci, a global leader in breakthrough biomanufacturing technologies, today announced that it is further expanding its offices and laboratory facilities. “We’ve seen a significant increase in partnership deal flow, which is a testament to the innovation and quality of work performed by our scientists,” said CEO and Founder, Sean McClain …

AbSci wins 2017 OEN ‘Start-up’ Award

AbSci wins 2017 OEN ‘Start-up’ Award

Oct 26, 2017. Companies in biotech, security software and cloud management were among the big winners Wednesday night at the 24th Annual OEN Tom Holce Entrepreneurship Awards.Hundreds of Oregon business community members turned out for the event at the Oregon...
AbSci Raises Series B Financing

AbSci Raises Series B Financing

AbSci, a global leader in breakthrough biomanufacturing technologies, announced that it closed its Series B financing round for an undisclosed amount. The round includes previous investors along with several new investors …

US Patent Granted for SoluPro™ Technology

US Patent Granted for SoluPro™ Technology

Vancouver, WA – April 11, 2017 United States Patent No. 9,617,335 was issued today to AbSci, an industry leader in biomanufacturing innovation, for its SoluPro™ protein expression system, which produces complex therapeutic proteins at unparalleled yield and throughput...
AbSci Receives European Patent on its SoluPro™ Expression Platform

AbSci Receives European Patent on its SoluPro™ Expression Platform

AbSci a global leader in biomanufacturing technologies, was granted a European regional patent today for its SoluPro™ protein production technology. “Many years of discovery went into developing the SoluPro™ expression platform. The SoluPro™ technology provides a revolutionary solution to one of biomanufacturing’s ongoing challenges …